A multicenter, prospective, observational study for the control of delayed chemotherapy-induced nausea and vomiting for upper gastrointestinal cancer
Not Applicable
Recruiting
- Conditions
- pper gastrointestinal cancer
- Registration Number
- JPRN-UMIN000052322
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 135
Inclusion Criteria
Not provided
Exclusion Criteria
1. Cases in which emetic events are observed due to factors other than cancer chemotherapy (e.g., emetic events due to passage obstruction due to the underlying disease, emetic events due to brain metastases) 2. Cases receiving continuous systemic administration of steroids exceeding 10 mg/day of prednisone equivalent. 3. Cases in which the attending physician determines that enrollment in this study is inappropriate 4. Cases with a history of hypersensitivity to the components of Fosnetupitant, Palonosetron, and Dexamethasone 5. Pregnant women or women who may be pregnant
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method